Search tips
Search criteria 


Logo of heartHeartVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Heart. 1996 December; 76(6): 477–482.
PMCID: PMC484597

Natural variability of transient myocardial ischaemia during daily life: an obstacle when assessing efficacy of anti-ischaemic agents?


OBJECTIVE: To assess the degree of variability of transient myocardial ischaemia during daily life in patients with coronary artery disease, which could confound the interpretation of trials of the therapeutic effects of anti-ischaemic agents. DESIGN: Prospective method evaluation. SETTING: Tertiary referral centre, outpatient clinic. PATIENTS: Patients with stable angina, confirmed coronary artery disease, and a positive treadmill exercise test for ischaemia. Patients were not preselected on the basis of prior documented transient ischaemia during ambulatory ST segment monitoring. INTERVENTIONS: A simulated drug-study with 4 monitoring phases in 16 subjects. To minimise variability in ischaemic activity, patients underwent weekly 48 hour ambulatory ST segment monitoring outside hospital off all prophylactic therapy on the same weekdays for 4 weeks. MAIN OUTCOME MEASURE: Variability in the frequency and duration of transient myocardial ischaemia. RESULTS: There was marked variability in both ischaemic activity and mean duration of ischaemia in patients with confirmed ischaemia, the greatest degree of variability being between patients and from day to day within weeks within patients, with a further contribution to variability being noted between fortnights within patients. CONCLUSIONS: Despite assessment off all therapy and an adequate period of monitoring (48 hours) with small intervals between monitoring periods (5 days), marked variability in ischaemic activity was noted, and regression towards the mean was clearly shown. Ambulatory ST segment monitoring outside hospital is not a reliable method for assessing the therapeutic effects of anti-ischaemic agents.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mulcahy D, Keegan J, Crean P, Quyyumi A, Shapiro L, Wright C, Fox K. Silent myocardial ischaemia in chronic stable angina: a study of its frequency and characteristics in 150 patients. Br Heart J. 1988 Nov;60(5):417–423. [PMC free article] [PubMed]
  • Deanfield JE, Maseri A, Selwyn AP, Ribeiro P, Chierchia S, Krikler S, Morgan M. Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet. 1983 Oct 1;2(8353):753–758. [PubMed]
  • Tzivoni D, Gavish A, Benhorin J, Banai S, Keren A, Stern S. Day-to-day variability of myocardial ischemic episodes in coronary artery disease. Am J Cardiol. 1987 Nov 1;60(13):1003–1005. [PubMed]
  • Nabel EG, Barry J, Rocco MB, Campbell S, Mead K, Fenton T, Orav EJ, Selwyn AP. Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. Circulation. 1988 Jul;78(1):60–67. [PubMed]
  • Celermajer DS, Spiegelhalter DJ, Deanfield M, Deanfield JE. Variability of episodic ST segment depression in chronic stable angina: implications for individual and group trials of therapeutic efficacy. J Am Coll Cardiol. 1994 Jan;23(1):66–73. [PubMed]
  • Tzivoni D, Weisz G, Gavish A, Zin D, Keren A, Stern S. Comparison of mortality and myocardial infarction rates in stable angina pectoris with and without ischemic episodes during daily activities. Am J Cardiol. 1989 Feb 1;63(5):273–276. [PubMed]
  • Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990 Mar;81(3):748–756. [PubMed]
  • Mulcahy D, Knight C, Patel D, Curzen N, Cunningham D, Wright C, Clarke D, Purcell H, Sutton G, Fox K. Detection of ambulatory ischaemia is not of practical clinical value in the routine management of patients with stable angina. A long-term follow-up study. Eur Heart J. 1995 Mar;16(3):317–324. [PubMed]
  • Quyyumi AA, Panza JA, Diodati JG, Callahan TS, Bonow RO, Epstein SE. Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease. J Am Coll Cardiol. 1993 Mar 1;21(3):700–708. [PubMed]
  • Benhorin J, Banai S, Moriel M, Gavish A, Keren A, Stern S, Tzivoni D. Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes. Circulation. 1993 Mar;87(3):808–814. [PubMed]
  • Khurmi NS, Raftery EB. Reproducibility and validity of ambulatory ST segment monitoring in patients with chronic stable angina pectoris. Am Heart J. 1987 May;113(5):1091–1096. [PubMed]
  • Mulcahy D, Keegan J, Sparrow J, Park A, Wright C, Fox K. Ischemia in the ambulatory setting--the total ischemic burden: relation to exercise testing and investigative and therapeutic implications. J Am Coll Cardiol. 1989 Nov 1;14(5):1166–1172. [PubMed]
  • Bland JM, Altman DG. Some examples of regression towards the mean. BMJ. 1994 Sep 24;309(6957):780–780. [PMC free article] [PubMed]
  • Kunkes SH, Pichard AD, Smith H, Jr, Gorlin R, Herman MV, Kupersmith J. Silent ST segment deviations and extent of coronary artery disease. Am Heart J. 1980 Dec;100(6 Pt 1):813–820. [PubMed]
  • Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug;90(2):762–768. [PubMed]
  • Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol. 1994 Nov 15;24(6):1460–1467. [PubMed]

Articles from Heart are provided here courtesy of BMJ Group